vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.
Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $62.1M, roughly 1.5× Cytek Biosciences, Inc.). On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 2.3%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 13.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...
CTKB vs PACK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $93.7M |
| Net Profit | $-44.1M | — |
| Gross Margin | 52.9% | 39.0% |
| Operating Margin | -9.0% | -1.0% |
| Net Margin | -70.9% | — |
| Revenue YoY | 8.1% | 2.3% |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $93.7M | ||
| Q3 25 | $52.3M | $83.6M | ||
| Q2 25 | $45.6M | $77.8M | ||
| Q1 25 | $41.5M | $77.6M | ||
| Q4 24 | $57.5M | $91.6M | ||
| Q3 24 | $51.5M | $78.6M | ||
| Q2 24 | $46.6M | $72.8M | ||
| Q1 24 | $44.9M | $72.5M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $-10.4M | ||
| Q2 25 | $-5.6M | $-7.5M | ||
| Q1 25 | $-11.4M | $-10.9M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $-8.1M | ||
| Q2 24 | $-10.4M | $5.5M | ||
| Q1 24 | $-6.2M | $-8.1M |
| Q4 25 | 52.9% | 39.0% | ||
| Q3 25 | 52.7% | 41.1% | ||
| Q2 25 | 52.3% | 37.1% | ||
| Q1 25 | 48.6% | 39.8% | ||
| Q4 24 | 58.5% | 45.2% | ||
| Q3 24 | 56.3% | 43.8% | ||
| Q2 24 | 54.6% | 43.5% | ||
| Q1 24 | 51.3% | 44.6% |
| Q4 25 | -9.0% | -1.0% | ||
| Q3 25 | -17.6% | -6.8% | ||
| Q2 25 | -23.3% | -12.5% | ||
| Q1 25 | -36.1% | -10.3% | ||
| Q4 24 | 5.2% | 1.5% | ||
| Q3 24 | -8.2% | -5.3% | ||
| Q2 24 | -18.3% | -7.1% | ||
| Q1 24 | -23.9% | -6.6% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | -12.4% | ||
| Q2 25 | -12.2% | -9.6% | ||
| Q1 25 | -27.5% | -14.0% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | -10.3% | ||
| Q2 24 | -22.4% | 7.6% | ||
| Q1 24 | -13.8% | -11.2% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.12 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.13 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $63.0M |
| Total DebtLower is stronger | — | $401.9M |
| Stockholders' EquityBook value | $341.7M | $534.9M |
| Total Assets | $461.5M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.75× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $63.0M | ||
| Q3 25 | $93.3M | $49.9M | ||
| Q2 25 | $75.5M | $49.2M | ||
| Q1 25 | $95.3M | $65.5M | ||
| Q4 24 | $98.7M | $76.1M | ||
| Q3 24 | $162.3M | $69.5M | ||
| Q2 24 | $177.9M | $65.1M | ||
| Q1 24 | $168.8M | $55.1M |
| Q4 25 | — | $401.9M | ||
| Q3 25 | — | $403.1M | ||
| Q2 25 | — | $403.1M | ||
| Q1 25 | — | $405.2M | ||
| Q4 24 | — | $406.4M | ||
| Q3 24 | — | $403.2M | ||
| Q2 24 | — | $396.1M | ||
| Q1 24 | — | $396.7M |
| Q4 25 | $341.7M | $534.9M | ||
| Q3 25 | $378.6M | $537.8M | ||
| Q2 25 | $377.6M | $539.0M | ||
| Q1 25 | $379.6M | $544.1M | ||
| Q4 24 | $395.7M | $548.1M | ||
| Q3 24 | $385.5M | $564.3M | ||
| Q2 24 | $389.1M | $566.2M | ||
| Q1 24 | $392.6M | $560.0M |
| Q4 25 | $461.5M | $1.1B | ||
| Q3 25 | $494.9M | $1.1B | ||
| Q2 25 | $493.3M | $1.1B | ||
| Q1 25 | $482.6M | $1.1B | ||
| Q4 24 | $499.5M | $1.1B | ||
| Q3 24 | $491.2M | $1.1B | ||
| Q2 24 | $483.7M | $1.1B | ||
| Q1 24 | $492.1M | $1.1B |
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $19.5M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $19.5M | ||
| Q3 25 | $-3.9M | $8.5M | ||
| Q2 25 | $108.0K | $-3.6M | ||
| Q1 25 | $-125.0K | $-1.3M | ||
| Q4 24 | $2.0M | $6.5M | ||
| Q3 24 | $13.2M | $10.1M | ||
| Q2 24 | $6.2M | $19.6M | ||
| Q1 24 | $4.0M | $5.2M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 3.56× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
